Please use this identifier to cite or link to this item:
https://doi.org/10.1186/1477-7819-12-88
Title: | Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: A case report and review of the literature | Authors: | Ho, C.W.G Mantoo, S Lim, C.H Wong, C.Y |
Keywords: | CD5 antigen common acute lymphoblastic leukemia antigen cyclophosphamide doxorubicin epidermal growth factor receptor 2 estrogen receptor prednisolone progesterone receptor protein bcl 6 rituximab vincristine sulfate acute kidney failure aged article B lymphocyte bone marrow biopsy breast carcinoma cancer chemotherapy cancer prognosis case report CD3+ T lymphocyte clinical feature diabetes mellitus endometrium carcinoma female fever fine needle aspiration biopsy flu like syndrome hemodialysis histology human human tissue hyperlipidemia hypertension intraductal carcinoma karyotyping large cell lymphoma mastectomy mental health neutropenia paraneoplastic syndrome positron emission tomography primary tumor protein expression sepsis tumor cell destruction Aged Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Carcinoma, Ductal, Breast Combined Modality Therapy Female Humans Lymphoma, Large B-Cell, Diffuse Mastectomy Neoplasm Invasiveness Neoplasms, Multiple Primary Prognosis |
Issue Date: | 2014 | Citation: | Ho, C.W.G, Mantoo, S, Lim, C.H, Wong, C.Y (2014). Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: A case report and review of the literature. World Journal of Surgical Oncology 12 (1) : 88. ScholarBank@NUS Repository. https://doi.org/10.1186/1477-7819-12-88 | Rights: | Attribution 4.0 International | Abstract: | Primary breast lymphomas (PBLs) represent less than 1% of all breast malignancies. Intravascular large B-cell lymphoma (ILBCL) is a rare, aggressive form of extranodal lymphoma. Breast involvement has only been described in the literature once previously. ILBCL is characterized by the proliferation of tumour cells within the lumen of small vessels of involved organs, resulting in their eventual occlusion. Clinical features are often vague, diagnosis is difficult and delayed, and prognosis is usually poor. We report the first ever case of synchronous ILBCL and invasive ductal carcinoma (IDC) of the breast in a patient presenting with pyrexia of unknown origin and altered mental status who underwent modified radical mastectomy and subsequent chemotherapy, and review the literature regarding intravascular large B-cell lymphoma, PBLs and synchronous carcinomas and lymphomas of the breast. © 2014 Ho et al.; licensee BioMed Central Ltd. | Source Title: | World Journal of Surgical Oncology | URI: | https://scholarbank.nus.edu.sg/handle/10635/181505 | ISSN: | 14777819 | DOI: | 10.1186/1477-7819-12-88 | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_1477-7819-12-88.pdf | 2.73 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License